XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues    
Gross premiums written (Note 5) $ 4,155,503 $ 3,990,684
Net premiums written (Note 5) 3,443,529 3,199,573
Decrease (increase) in unearned premiums (722,748) (755,663)
Net premiums earned (Note 5) 2,720,781 2,443,910
Net investment income (Note 3) 405,353 390,775
Net foreign exchange gains (losses) (7,328) (35,683)
Equity in earnings (losses) of other ventures (Note 3) 17,828 14,127
Other income (loss) 914 (50)
Net realized and unrealized gains (losses) on investments (Note 3) 332,940 (213,654)
Total revenues 3,470,488 2,599,425
Expenses    
Net claims and claim expenses incurred (Notes 5 and 6) 2,743,758 1,166,123
Acquisition expenses 647,435 630,921
Operational expenses 100,185 106,184
Corporate expenses 22,810 39,252
Interest expense (Note 7) 27,086 23,104
Total expenses 3,541,274 1,965,584
Income (loss) before taxes (70,786) 633,841
Income tax benefit (expense) 45,525 (15,372)
Net income (loss) (25,261) 618,469
Net (income) loss attributable to redeemable noncontrolling interests 195,252 (244,827)
Net income (loss) attributable to RenaissanceRe 169,991 373,642
Dividends on preference shares (Note 10) (8,844) (8,844)
Net income (loss) available (attributable) to RenaissanceRe common shareholders $ 161,147 $ 364,798
Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – basic (in dollars per share) $ 3.29 $ 6.96
Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – diluted (in dollars per share) $ 3.27 $ 6.94